• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝窦微环境在非酒精性脂肪性肝炎中的作用:发病机制、动物模型及治疗前景

The role of hepatic sinusoidal microenvironment in NASH: pathogenesis, animal models, and therapeutic prospects.

作者信息

Tan Wanying, Deng Jiangting, Qi Lingjun, Tan Zhenghuai

机构信息

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

Sichuan Academy of Chinese Medicine Sciences, Sichuan Provincial Key Laboratory of Quality and Innovation Research of Chinese Materia Medica, Chengdu, Sichuan, China.

出版信息

Front Pharmacol. 2025 Apr 28;16:1467950. doi: 10.3389/fphar.2025.1467950. eCollection 2025.

DOI:10.3389/fphar.2025.1467950
PMID:40356963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12066276/
Abstract

The incidence of nonalcoholic steatohepatitis (NASH) is increasing annually, posing a significant threat to human health. NASH is typified by hepatic steatosis, inflammation, and hepatocellular injury, frequently culminating in fibrosis and cirrhosis. Yet, the precise pathogenesis of NASH remains to be fully elucidated. The hepatic sinusoid, which serves as the fundamental structural and functional unit of the liver, is intricately composed of endothelial cells, Kupffer cells, and hepatic stellate cells. Consequently, the homeostasis of the hepatic sinusoidal microenvironment may exert a pivotal influence on the progression and prognosis of NASH. However, the limitations of current NASH animal models have significantly impeded advancements in understanding the disease's pathogenesis and the development of effective therapeutic interventions. In light of these challenges, this review endeavors to delve deeper into the critical role of hepatic sinusoidal microenvironment homeostasis in the pathogenesis of NASH, critically analyze the commonly employed animal models, and comprehensively summarize the most recent and promising developments in drug research and development. It is anticipated that these efforts will collectively expedite the advancement of the field of NASH research and therapeutic innovation.

摘要

非酒精性脂肪性肝炎(NASH)的发病率逐年上升,对人类健康构成重大威胁。NASH的典型特征是肝脂肪变性、炎症和肝细胞损伤,常最终发展为纤维化和肝硬化。然而,NASH的确切发病机制仍有待充分阐明。肝窦作为肝脏的基本结构和功能单位,由内皮细胞、库普弗细胞和肝星状细胞复杂地组成。因此,肝窦微环境的稳态可能对NASH的进展和预后产生关键影响。然而,当前NASH动物模型的局限性严重阻碍了在理解该疾病发病机制和开发有效治疗干预措施方面的进展。鉴于这些挑战,本综述致力于更深入地探讨肝窦微环境稳态在NASH发病机制中的关键作用,批判性地分析常用的动物模型,并全面总结药物研发的最新且有前景的进展。预计这些努力将共同加速NASH研究和治疗创新领域的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ffe/12066276/0cdbb586ae79/fphar-16-1467950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ffe/12066276/1b0cd02a0a39/fphar-16-1467950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ffe/12066276/0cdbb586ae79/fphar-16-1467950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ffe/12066276/1b0cd02a0a39/fphar-16-1467950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ffe/12066276/0cdbb586ae79/fphar-16-1467950-g002.jpg

相似文献

1
The role of hepatic sinusoidal microenvironment in NASH: pathogenesis, animal models, and therapeutic prospects.肝窦微环境在非酒精性脂肪性肝炎中的作用:发病机制、动物模型及治疗前景
Front Pharmacol. 2025 Apr 28;16:1467950. doi: 10.3389/fphar.2025.1467950. eCollection 2025.
2
The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis.非酒精性脂肪性肝炎相关肝纤维化中肝窦内皮细胞与肝微环境的串扰。
Front Immunol. 2022 Jun 28;13:936196. doi: 10.3389/fimmu.2022.936196. eCollection 2022.
3
Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的人源原代细胞三维模型中肝星状细胞和肝窦内皮细胞的作用。
Am J Pathol. 2024 Mar;194(3):353-368. doi: 10.1016/j.ajpath.2023.12.005. Epub 2023 Dec 28.
4
[Research progress of hepatic non-parenchymal cells in nonalcoholic steatohepatitis].[非酒精性脂肪性肝炎中肝脏非实质细胞的研究进展]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jul 20;29(7):711-715. doi: 10.3760/cma.j.cn501113-20200301-00080.
5
Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase.Notch 触发的肝窦内皮细胞失调通过内皮型一氧化氮合酶加重非酒精性脂肪性肝炎。
Hepatology. 2022 Sep;76(3):742-758. doi: 10.1002/hep.32332. Epub 2022 Feb 3.
6
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎中肝脏巨噬细胞与周围细胞的串扰。
Front Immunol. 2020 Jun 24;11:1169. doi: 10.3389/fimmu.2020.01169. eCollection 2020.
7
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
8
Endothelial group IVA phospholipase A promotes hepatic fibrosis with sinusoidal capillarization in the early stage of non-alcoholic steatohepatitis in mice.内皮细胞组 IVA 磷脂酶 A 促进非酒精性脂肪性肝炎早期小鼠肝纤维化伴窦状隙毛细血管化。
Life Sci. 2022 Apr 1;294:120355. doi: 10.1016/j.lfs.2022.120355. Epub 2022 Jan 29.
9
Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.肝脏窦状内皮细胞在非酒精性脂肪性肝病/非酒精性脂肪性肝炎进展中的关键作用。
Lab Invest. 2015 Oct;95(10):1130-44. doi: 10.1038/labinvest.2015.95. Epub 2015 Jul 27.
10
Human Nonalcoholic Steatohepatitis on a Chip.人源非酒精性脂肪性肝炎芯片模型。
Hepatol Commun. 2020 Nov 29;5(2):217-233. doi: 10.1002/hep4.1647. eCollection 2021 Feb.

本文引用的文献

1
Impact of Liver Sympathetic Nervous System on Liver Fibrosis and Regeneration After Bile Duct Ligation in Rats.肝脏交感神经系统对大鼠胆管结扎后肝纤维化和肝再生的影响
J Mol Neurosci. 2024 Jan 6;74(1):4. doi: 10.1007/s12031-023-02176-1.
2
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.奥贝胆酸治疗非酒精性脂肪性肝炎所致肝硬化前期纤维化的REGENERATE试验的一项新的疗效和安全性分析结果。
J Hepatol. 2023 Nov;79(5):1110-1120. doi: 10.1016/j.jhep.2023.07.014. Epub 2023 Jul 28.
3
Macrophages and the development and progression of non-alcoholic fatty liver disease.
巨噬细胞与非酒精性脂肪性肝病的发生和进展。
Front Immunol. 2023 Jun 12;14:1195699. doi: 10.3389/fimmu.2023.1195699. eCollection 2023.
4
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
5
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms.抗结核药物性肝损伤:分子机制的最新认识。
Drug Metab Rev. 2023 Aug;55(3):239-253. doi: 10.1080/03602532.2023.2215478. Epub 2023 May 22.
6
Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity.肝硬化时肾上腺素能阻滞剂的神经免疫调节:肝星状细胞活性的调节。
Ann Med. 2023 Dec;55(1):543-557. doi: 10.1080/07853890.2022.2164047.
7
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial.特利福昔布治疗非酒精性脂肪性肝炎:一项适应性、随机、安慰剂对照的 2a/2b 期试验。
Nat Med. 2023 Feb;29(2):392-400. doi: 10.1038/s41591-022-02200-8. Epub 2023 Feb 16.
8
Liraglutide Accelerates Ischemia-Induced Angiogenesis in a Murine Diabetic Model.利拉鲁肽促进糖尿病小鼠缺血诱导的血管生成。
J Am Heart Assoc. 2023 Feb 21;12(4):e026586. doi: 10.1161/JAHA.122.026586. Epub 2023 Feb 15.
9
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
10
The evolving role of liver sinusoidal endothelial cells in liver health and disease.肝窦内皮细胞在肝脏健康和疾病中的作用演变。
Hepatology. 2023 Aug 1;78(2):649-669. doi: 10.1097/HEP.0000000000000207. Epub 2023 Jan 3.